Active, Not Recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT03862157 Conditions Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blood Coagulation Disorders, +43 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
